Breakingviews - Bristol-Myers takes $74 bln bet against the market

📆 04/01/2019 5:01:00
📰 Reuters

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 97%

España Noticias Noticias

España Últimas Noticias,España Titulares

(Reuters Breakingviews) - Bristol-Myers Squibb is taking a $74 billion bet again...

Escribir Comentario

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Bristol-Myers takes $74 bln bet against the marketThere are good reasons to buy rival oncology giant Celgene. But cost cuts don’t cover the 54 pct premium and the target’s owners get the financial benefit. Bristol is hoping for luck in the courts and multiple regulatory approvals that Celgene’s shareholders were skeptical of.
Fuente: Breakingviews - 🏆 470. / 51 Leer más »

Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companiesHeavy debt, faltering in 2018, and cracks in the deal: Bristol-Myers Squibb's $74 billion acquisition of Celgene combines 2 troubled companies. That's like merging Deutsche Bank and Commerzbank. Guess 1-(-1) = 2
Fuente: CNBC - 🏆 12. / 72 Leer más »